Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease

<p dir="ltr">Accumulation of advanced glycation endproducts (AGEs) is linked to decline in renal function, particularly in patients with diabetes. Major forms of AGEs in serum are protein-bound AGEs and AGE free adducts. In this study, we assessed levels of AGEs in subjects with and...

Full description

Saved in:

Bibliographic Details
Main Author:	Naila Rabbani (291722) (author)
Other Authors:	Antonysunil Adaikalakoteswari (325054) (author), James R. Larkin (12221192) (author), Sianna Panagiotopoulos (3505712) (author), Richard J. MacIsaac (9718733) (author), Dennis K. Yue (19482394) (author), Gregory R. Fulcher (7774967) (author), Matthew A. Roberts (3056739) (author), Merlin Thomas (6252059) (author), Elif Ekinci (3913966) (author), Paul J. Thornalley (291723) (author)
Published:	2022
Subjects:	Biomedical and clinical sciences Clinical sciences Medical biochemistry and metabolomics chronic kidney disease diabetes glycation methylglyoxal estimated glomerular filtration rate
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Analysis of Serum Advanced Glycation Endproducts Reveals Methylglyoxal-Derived Advanced Glycation MG-H1 Free Adduct Is a Risk Marker in Non-Diabetic and Diabetic Chronic Kidney Disease

Similar Items